SCHEMBL18216418

SCHEMBL18216418

CC(C)NC(=O)c1nc[nH]c1C(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(F)cc2Cl)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.44
▸ MEN1 O00255 5/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 1/20 0.43
▸ MAPT P10636 6/20 0.41
▸ POLB P06746 4/20 0.41
▸ MAPK1 P28482 4/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CHRM4 P08173 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ CCNT1 O60563 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ ALPL P05186 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201142 0.92 HPGD (0.49) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20201158 0.91 MEN1 (0.41) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20201159 0.91 MEN1 (0.41) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20201157 0.91 MEN1 (0.41) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL18216464 0.90 KMT2A (0.47) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20205096 0.89 HPGD (0.40) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20205023 0.89 HPGD (0.40) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20205140 0.88 HPGD (0.39) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL18216473 0.88 HPGD (0.43) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20201145 0.87 HPGD (0.41) KMT2AMEN1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 — — US disclosed
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 — — US disclosed
WO-2016177658-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-11-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES C1R, C9, C1S KMT2A 3502/4885MEN1 56/4885ALDH1A1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback